Zhejiang Anglikang Pharmaceutical Co Ltd. Stock Analysis 002940.SZ

Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the research, development, production & sales of chemical raw materials and preparations. The company is headquartered in Shaoxing, Zhejiang and currently employs 1,236 full-time employees. The company went IPO on 2018-10-23. The firm's products mainly include the research and development, production and sales of chemical raw materials, chemical preparations, pharmaceutical excipients and special intermediates. The firm's main drugs cover multiple drug use areas such as anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The firm's pharmaceutical excipients are pharmaceutical hollow capsule products, which are mainly used in chemical preparations and traditional Chinese medicine preparations. The firm's specialty intermediates are mainly used in functional products such as cosmetics, nutritional products and feed.